Search

Your search keyword '"Maleki, Iradj"' showing total 208 results

Search Constraints

Start Over You searched for: Author "Maleki, Iradj" Remove constraint Author: "Maleki, Iradj"
208 results on '"Maleki, Iradj"'

Search Results

2. Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study

3. Sex and age differences in inflammatory bowel disease patients; a nationwide study based on Iranian Registry of Crohn's and Colitis (IRCC).

4. Clinical Phenotype and Disease Course of Inflammatory Bowel Disease: A Comparison Between Sporadic and Familial Cases

5. Effectiveness of a Multispecies Synbiotic on Functional Constipation: A Randomized Controlled Trial

6. Identification of Novel Gastric Adenocarcinoma Susceptibility Loci Via Genome-Wide Association Analysis in West Asians and Large-Scale Replication in East Asians

8. Prevalence and risk factors of gastroesophageal reflux disease symptoms in Mazandaran, North of Iran: A Tabari cohort study.

9. Comparison of Disease Phenotype and Course among Elderly- and Early-Onset Inflammatory Bowel Diseases in the Middle East

10. CD4+CD25+CD127low FoxP3+ regulatory T cells in Crohn’s disease

12. Face‐to‐face interviews versus Internet surveys: Comparison of two data collection methods in the Rome foundation global epidemiology study: Implications for population‐based research

13. Epidemiological, Endoscopic, Clinical, and Pathological Features of Patients with Celiac Diseases in Southern Littoral of Caspian Sea.

14. Non-inferiority of reverse hybrid regimen versus standard concomitant regimen for H. pylori eradication in a randomized-controlled trial.

15. Effects of 14-days bismuth- and tetracycline-containing quadruple therapy with concomitant regimen for the first line Helicobacter pylori eradication.

18. A Supporting System for Management of Patients with Inflammatory Bowel Disease during COVID-19 Outbreak: Iranian Experience-Study Protocol

19. Evaluation of demographic, pathologic, and clinical characteristics and overall survival of patients with colon cancer in Northern Iran (Mazandaran Province) during 2012-2019

20. Outcomes of COVID-19 in Patients with Inflammatory Bowel Disease: Comparison with Household Members and the Role of IBD Medications

21. Clinical Phenotype and Disease Course of Inflammatory Bowel Disease: A Comparison Between Sporadic and Familial Cases

24. Erratum to: SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter Phase III Clinical Trial

25. INSULIN AND INSULIN RECEPTOR GENE POLYMORPHISMS AND SUSCEPTIBILITY TO NONALCOHOLIC FATTY LIVER DISEASE

28. Susceptibility of Patients with Inflammatory Bowel Disease to COVID-19 Compared with Their Households.

29. Efficacy of 14-day concomitant quadruple therapy and 14-day high-dose dual therapy on H. pylori eradication.

30. INSULIN AND INSULIN RECEPTOR GENE POLYMORPHISMS AND SUSCEPTIBILITY TO NONALCOHOLIC FATTY LIVER DISEASE

32. 273 PREVALENCE AND IMPACT OF FUNCTIONAL DYSPEPSIA ACCORDING TO THE ROME IV DEFINITIONS IN A GLOBAL EPIDEMIOLOGICAL SURVEY

33. 405 ROME IV AND ROME III IRRITABLE BOWEL SYNDROME (IBS) ACROSS THE GLOBE: FINDINGS OF A POPULATION-BASED INTERNET SURVEY OF ADULTS IN 26 COUNTRIES

34. Opium Addiction and COVID-19: Truth or False Beliefs

36. The combination of sofosbuvir and daclatasvir is effective and safe in treating patients with hepatitis C and severe renal impairment

37. Ендоскопічні дані та наслідки кровотечі з верхніх відділів шлунково-кишкового тракту в пацієнтів у північній частині Ірану, яких направили у відділення невідкладної допомоги

39. Endoscopic findings and outcomes of upper gastrointestinal bleeding patients in northern Iran population referred to the emergency department

40. Immunologic markers, vasculitis-associated autoantibodies, and complement levels in patients with COVID-19.

41. Iranian Registry of Crohn’s and Colitis: study profile of first nation-wide inflammatory bowel disease registry in Middle East

43. THU-162-The combination of sofosbuvir and daclatasvir is well tolerated and extremely effective in treating patients with hepatitis C with severe renal impairment including hemodialysis patinets

46. Simultaneous Esophageal Squamous Cell Carcinoma and Adenocarcinoma: A Case Report

47. Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in COVID-19 Patients and Control Group and Relationship with Disease Prognosis.

48. Positive association between severity of COVID-19 infection and liver damage: a systematic review and meta-analysis.

49. Helicobacter pylori eradication in the management of glaucoma.

Catalog

Books, media, physical & digital resources